101 related articles for article (PubMed ID: 17294191)
21. The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study.
El-Kattan AF; Poe J; Buchholz L; Thomas HV; Brodfuehrer J; Clark A
Drug Metab Lett; 2008 Apr; 2(2):120-4. PubMed ID: 19356080
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
[TBL] [Abstract][Full Text] [Related]
24. Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness.
Al-Ghananeem AM; Malkawi AH; Crooks PA
Drug Dev Ind Pharm; 2007 May; 33(5):577-82. PubMed ID: 17520450
[TBL] [Abstract][Full Text] [Related]
25. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
26. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
27. A pharmacokinetic study on a novel anti-HBV agent imidol hydrochloride in rats.
Liu Z; Peng Y; Ma B; Bi K; Liu Y; Sun G; Ping G; Guo Y
Int J Pharm; 2014 Jan; 461(1-2):514-8. PubMed ID: 24333907
[TBL] [Abstract][Full Text] [Related]
28. Comparison of oral bioavailability of genistein and genistin in rats.
Kwon SH; Kang MJ; Huh JS; Ha KW; Lee JR; Lee SK; Lee BS; Han IH; Lee MS; Lee MW; Lee J; Choi YW
Int J Pharm; 2007 Jun; 337(1-2):148-54. PubMed ID: 17280808
[TBL] [Abstract][Full Text] [Related]
29. Effect of carbamazepine on the pharmacokinetic parameters of CDRI-97/78 following coadministration to rats.
Kushwaha HN; Misra A; Gautam N; Singh Y; Kumar H; Siddiqui HH; Singh SK
Drug Res (Stuttg); 2013 Jun; 63(6):282-8. PubMed ID: 23558601
[TBL] [Abstract][Full Text] [Related]
30. In-situ absorption, protein binding and pharmacokinetic studies of S002-853, a novel antidiabetic and antidyslipidaemic flavone derivative in rats.
Gautam N; Kushwaha HN; Pratap R; Singh SK
J Pharm Pharmacol; 2010 May; 62(5):604-9. PubMed ID: 20609062
[TBL] [Abstract][Full Text] [Related]
31. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
32. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M
J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735
[TBL] [Abstract][Full Text] [Related]
33. Determination of bencycloquidium bromide in rat plasma by liquid chromatography-electrospray ionization-mass spectrometry.
Xu Q; Ding L; Liu W; Bian X; Tang W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):209-14. PubMed ID: 17055347
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and metabolism profiles of protostemonine in rat by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Han H; Yang L; Ding Y; Ji G; Zhang T
J Pharm Biomed Anal; 2016 Jan; 117():266-75. PubMed ID: 26397206
[TBL] [Abstract][Full Text] [Related]
35. Preclinical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropregnenolone, an antihyperlipidemic agent, in rats.
Suryawanshi S; Wahajuddin ; Gupta RC; Singh SK
J Pharm Pharmacol; 2011 Jan; 63(1):41-8. PubMed ID: 21155814
[TBL] [Abstract][Full Text] [Related]
36. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats.
Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X
J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic characterization of the novel TAZ modulator TM-25659 using a multicompartment kinetic model in rats and a possibility of its drug-drug interactions in humans.
Lee KR; Choi SH; Song JS; Kwak EY; Chae YJ; Im SH; Lee BH; Seo H; Cho WK; Kim MS; Kim NJ; Ahn SH; Bae MA
Xenobiotica; 2013 Feb; 43(2):193-200. PubMed ID: 22856387
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of isochlorgenic acid C in rats by HPLC-MS: Absolute bioavailability and dose proportionality.
Huang LH; Xiong XH; Zhong YM; Cen MF; Cheng XG; Wang GX; Zang LQ; Wang SJ
J Ethnopharmacol; 2016 Jun; 185():105-9. PubMed ID: 26972507
[TBL] [Abstract][Full Text] [Related]
39. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
[TBL] [Abstract][Full Text] [Related]
40. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
